nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Rash—Floxuridine—stomach cancer	0.00808	0.00808	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Floxuridine—stomach cancer	0.00808	0.00808	CcSEcCtD
Ceftaroline fosamil—Headache—Floxuridine—stomach cancer	0.00803	0.00803	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mitomycin—stomach cancer	0.00795	0.00795	CcSEcCtD
Ceftaroline fosamil—Nausea—Floxuridine—stomach cancer	0.00761	0.00761	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Fluorouracil—stomach cancer	0.00729	0.00729	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Irinotecan—stomach cancer	0.00718	0.00718	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Docetaxel—stomach cancer	0.00713	0.00713	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Capecitabine—stomach cancer	0.00691	0.00691	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mitomycin—stomach cancer	0.00688	0.00688	CcSEcCtD
Ceftaroline fosamil—Renal failure—Irinotecan—stomach cancer	0.00673	0.00673	CcSEcCtD
Ceftaroline fosamil—Dizziness—Mitomycin—stomach cancer	0.00665	0.00665	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Fluorouracil—stomach cancer	0.00656	0.00656	CcSEcCtD
Ceftaroline fosamil—Infestation—Fluorouracil—stomach cancer	0.00656	0.00656	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mitomycin—stomach cancer	0.0064	0.0064	CcSEcCtD
Ceftaroline fosamil—Rash—Mitomycin—stomach cancer	0.00634	0.00634	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mitomycin—stomach cancer	0.00634	0.00634	CcSEcCtD
Ceftaroline fosamil—Headache—Mitomycin—stomach cancer	0.0063	0.0063	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Irinotecan—stomach cancer	0.00626	0.00626	CcSEcCtD
Ceftaroline fosamil—Nausea—Mitomycin—stomach cancer	0.00598	0.00598	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—stomach cancer	0.00561	0.00561	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Irinotecan—stomach cancer	0.00558	0.00558	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Irinotecan—stomach cancer	0.00555	0.00555	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Capecitabine—stomach cancer	0.00541	0.00541	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—stomach cancer	0.00519	0.00519	CcSEcCtD
Ceftaroline fosamil—Erythema—Fluorouracil—stomach cancer	0.00513	0.00513	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Docetaxel—stomach cancer	0.00497	0.00497	CcSEcCtD
Ceftaroline fosamil—Anaemia—Irinotecan—stomach cancer	0.00495	0.00495	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—stomach cancer	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Capecitabine—stomach cancer	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Anaemia—Fluorouracil—stomach cancer	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Docetaxel—stomach cancer	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Infestation—Docetaxel—stomach cancer	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Renal failure—Docetaxel—stomach cancer	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Capecitabine—stomach cancer	0.00464	0.00464	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Capecitabine—stomach cancer	0.00458	0.00458	CcSEcCtD
Ceftaroline fosamil—Infestation—Capecitabine—stomach cancer	0.00458	0.00458	CcSEcCtD
Ceftaroline fosamil—Renal failure—Capecitabine—stomach cancer	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Docetaxel—stomach cancer	0.00448	0.00448	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—stomach cancer	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Convulsion—Fluorouracil—stomach cancer	0.00444	0.00444	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Irinotecan—stomach cancer	0.00437	0.00437	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Capecitabine—stomach cancer	0.00434	0.00434	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Irinotecan—stomach cancer	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Irinotecan—stomach cancer	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Docetaxel—stomach cancer	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Docetaxel—stomach cancer	0.0042	0.0042	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Capecitabine—stomach cancer	0.00419	0.00419	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Fluorouracil—stomach cancer	0.00418	0.00418	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Docetaxel—stomach cancer	0.00417	0.00417	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Capecitabine—stomach cancer	0.00412	0.00412	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Fluorouracil—stomach cancer	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Fluorouracil—stomach cancer	0.0041	0.0041	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Capecitabine—stomach cancer	0.00406	0.00406	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Capecitabine—stomach cancer	0.00403	0.00403	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Docetaxel—stomach cancer	0.00386	0.00386	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Docetaxel—stomach cancer	0.00384	0.00384	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—stomach cancer	0.00379	0.00379	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—stomach cancer	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00377	0.00377	CcSEcCtD
Ceftaroline fosamil—Pain—Irinotecan—stomach cancer	0.00374	0.00374	CcSEcCtD
Ceftaroline fosamil—Constipation—Irinotecan—stomach cancer	0.00374	0.00374	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Capecitabine—stomach cancer	0.00373	0.00373	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Capecitabine—stomach cancer	0.00372	0.00372	CcSEcCtD
Ceftaroline fosamil—Erythema—Docetaxel—stomach cancer	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Docetaxel—stomach cancer	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Capecitabine—stomach cancer	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Erythema—Capecitabine—stomach cancer	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—stomach cancer	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Pain—Fluorouracil—stomach cancer	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Irinotecan—stomach cancer	0.00357	0.00357	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—stomach cancer	0.00355	0.00355	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—stomach cancer	0.00349	0.00349	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Irinotecan—stomach cancer	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Irinotecan—stomach cancer	0.00345	0.00345	CcSEcCtD
Ceftaroline fosamil—Anaemia—Docetaxel—stomach cancer	0.00342	0.00342	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—stomach cancer	0.00341	0.00341	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—stomach cancer	0.00341	0.00341	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—stomach cancer	0.00335	0.00335	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—stomach cancer	0.00335	0.00335	CcSEcCtD
Ceftaroline fosamil—Urticaria—Fluorouracil—stomach cancer	0.00332	0.00332	CcSEcCtD
Ceftaroline fosamil—Anaemia—Capecitabine—stomach cancer	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Fluorouracil—stomach cancer	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—stomach cancer	0.00328	0.00328	CcSEcCtD
Ceftaroline fosamil—Palpitations—Docetaxel—stomach cancer	0.00327	0.00327	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—stomach cancer	0.00323	0.00323	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—stomach cancer	0.00323	0.00323	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Irinotecan—stomach cancer	0.00322	0.00322	CcSEcCtD
Ceftaroline fosamil—Convulsion—Docetaxel—stomach cancer	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—stomach cancer	0.00319	0.00319	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—stomach cancer	0.00319	0.00319	CcSEcCtD
Ceftaroline fosamil—Palpitations—Capecitabine—stomach cancer	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—stomach cancer	0.00314	0.00314	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00313	0.00313	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—stomach cancer	0.0031	0.0031	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Fluorouracil—stomach cancer	0.00308	0.00308	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—stomach cancer	0.00306	0.00306	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—stomach cancer	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—stomach cancer	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Docetaxel—stomach cancer	0.00302	0.00302	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—stomach cancer	0.003	0.003	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—stomach cancer	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Irinotecan—stomach cancer	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Docetaxel—stomach cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Pruritus—Fluorouracil—stomach cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Docetaxel—stomach cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—stomach cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—stomach cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Docetaxel—stomach cancer	0.00293	0.00293	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—stomach cancer	0.00292	0.00292	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—stomach cancer	0.0029	0.0029	CcSEcCtD
Ceftaroline fosamil—Dizziness—Irinotecan—stomach cancer	0.00289	0.00289	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Capecitabine—stomach cancer	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—stomach cancer	0.00287	0.00287	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Fluorouracil—stomach cancer	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Capecitabine—stomach cancer	0.00286	0.00286	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Capecitabine—stomach cancer	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—stomach cancer	0.00283	0.00283	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—stomach cancer	0.00281	0.00281	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00279	0.00279	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—stomach cancer	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Vomiting—Irinotecan—stomach cancer	0.00278	0.00278	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—stomach cancer	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Dizziness—Fluorouracil—stomach cancer	0.00277	0.00277	CcSEcCtD
Ceftaroline fosamil—Rash—Irinotecan—stomach cancer	0.00275	0.00275	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Irinotecan—stomach cancer	0.00275	0.00275	CcSEcCtD
Ceftaroline fosamil—Headache—Irinotecan—stomach cancer	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—stomach cancer	0.0027	0.0027	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—stomach cancer	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—stomach cancer	0.00267	0.00267	CcSEcCtD
Ceftaroline fosamil—Vomiting—Fluorouracil—stomach cancer	0.00266	0.00266	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—stomach cancer	0.00265	0.00265	CcSEcCtD
Ceftaroline fosamil—Rash—Fluorouracil—stomach cancer	0.00264	0.00264	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Fluorouracil—stomach cancer	0.00264	0.00264	CcSEcCtD
Ceftaroline fosamil—Headache—Fluorouracil—stomach cancer	0.00262	0.00262	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—stomach cancer	0.00262	0.00262	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—stomach cancer	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—stomach cancer	0.0026	0.0026	CcSEcCtD
Ceftaroline fosamil—Nausea—Irinotecan—stomach cancer	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—stomach cancer	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Pain—Docetaxel—stomach cancer	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Constipation—Docetaxel—stomach cancer	0.00258	0.00258	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00252	0.00252	CcSEcCtD
Ceftaroline fosamil—Pain—Capecitabine—stomach cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Constipation—Capecitabine—stomach cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—stomach cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—stomach cancer	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Nausea—Fluorouracil—stomach cancer	0.00249	0.00249	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Docetaxel—stomach cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—stomach cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—stomach cancer	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—stomach cancer	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Capecitabine—stomach cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Docetaxel—stomach cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Docetaxel—stomach cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Urticaria—Capecitabine—stomach cancer	0.00232	0.00232	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Capecitabine—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Capecitabine—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—stomach cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Docetaxel—stomach cancer	0.00223	0.00223	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—stomach cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—stomach cancer	0.00218	0.00218	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—stomach cancer	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Capecitabine—stomach cancer	0.00215	0.00215	CcSEcCtD
Ceftaroline fosamil—Pruritus—Docetaxel—stomach cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—stomach cancer	0.00213	0.00213	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—stomach cancer	0.00213	0.00213	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—stomach cancer	0.00213	0.00213	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—stomach cancer	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Pruritus—Capecitabine—stomach cancer	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Docetaxel—stomach cancer	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—stomach cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—stomach cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—stomach cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Capecitabine—stomach cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—stomach cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Dizziness—Docetaxel—stomach cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—stomach cancer	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—stomach cancer	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Dizziness—Capecitabine—stomach cancer	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Vomiting—Docetaxel—stomach cancer	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Rash—Docetaxel—stomach cancer	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Docetaxel—stomach cancer	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Headache—Docetaxel—stomach cancer	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—stomach cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—stomach cancer	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Vomiting—Capecitabine—stomach cancer	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—stomach cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—stomach cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Rash—Capecitabine—stomach cancer	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Capecitabine—stomach cancer	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Headache—Capecitabine—stomach cancer	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—stomach cancer	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Nausea—Docetaxel—stomach cancer	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—stomach cancer	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—stomach cancer	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—stomach cancer	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Nausea—Capecitabine—stomach cancer	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—stomach cancer	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—stomach cancer	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—stomach cancer	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—stomach cancer	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—stomach cancer	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—stomach cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—stomach cancer	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—stomach cancer	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—stomach cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—stomach cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—stomach cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—stomach cancer	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—stomach cancer	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—stomach cancer	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—stomach cancer	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—stomach cancer	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—stomach cancer	0.00136	0.00136	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—stomach cancer	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—stomach cancer	0.00133	0.00133	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—stomach cancer	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—stomach cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—stomach cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—stomach cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—stomach cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—stomach cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—stomach cancer	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—stomach cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—stomach cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—stomach cancer	0.00112	0.00112	CcSEcCtD
